DEF: Greenwave Technology Solutions Annual Meeting Agenda

Sentiment:

Proxy Statement


Greenwave Technology Solutions announces its 2026 Annual Meeting of Stockholders, detailing proposals for director elections, auditor ratification, and a significant common stock issuance.

Capital raiseThe company entered into a Preferred Stock Purchase Agreement for the issuance and sale of 3,750 shares of Series B Preferred Stock in a private placement, raising aggregate proceeds of $3.75 million before fees and expenses.The proposed approval of the issuance of up to 3,571,429 shares of Common Stock upon conversion of the Series B Preferred Stock is to comply with Nasdaq Listing Rule 5635(d) and to allow for the full conversion of these shares.

Summary

  • Greenwave Technology Solutions, Inc. is holding its 2026 Annual Meeting of Stockholders virtually on December 7, 2026.
  • Key proposals include the election of three directors, ratification of RBSM LLP as the independent auditor for fiscal year 2026, and approval for the issuance of up to 3,571,429 shares of common stock upon conversion of Series B Preferred Stock.
  • The meeting will be conducted as a listen-only conference call.
  • The record date for voting eligibility is October 23, 2026, with 2,982,484 shares of common stock and 450,000 shares of Series A-1 Preferred Stock outstanding.
  • The company highlights extensive related-party transactions, primarily involving entities controlled by CEO Danny Meeks, including leases, equipment purchases, and property acquisitions.
  • The proposed issuance of common stock is to comply with Nasdaq Listing Rule 5635(d) and is a result of a private placement of Series B Preferred Stock.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this filing as having a slightly negative sentiment due to the significant dilution risk associated with the proposed share issuance and the ongoing related-party transactions, despite the procedural nature of a proxy statement.

Positives

  • The company is holding its annual meeting to ensure corporate governance and provide stockholders with voting opportunities.
  • RBSM LLP has served as the independent registered public accounting firm since 2017, indicating a stable auditor relationship.
  • The proposed issuance of Series B Preferred Stock raised $3.75 million in capital, providing necessary funding for the company.
  • The company has a robust corporate governance framework with established committees (Audit, Compensation, Sustainability, Nominating and Corporate Governance) and an insider trading policy.
  • Directors Lisa Lucas-Burke and Cheryl Lanthorn are considered independent by Nasdaq standards.

Negatives

  • The proposed issuance of up to 3,571,429 shares of common stock upon conversion of Series B Preferred Stock represents a significant potential dilution to existing shareholders.
  • The company has a history of extensive related-party transactions, particularly with entities controlled by CEO Danny Meeks, raising potential governance concerns.
  • The company's financial performance is not detailed in this proxy statement, but past net losses are referenced in the Pay Versus Performance table.
  • The company's CEO, Danny Meeks, has a substantial portion of his compensation deferred due to the company's financial condition, indicating liquidity challenges.
  • The termination of former CFO Isaac Dietrich in April 2025 suggests potential executive instability.

Risks

  • Dilution risk for existing common stockholders due to the potential issuance of up to 3,571,429 shares upon conversion of Series B Preferred Stock.
  • Potential for increased stock price volatility and adverse market price effects from the sale of shares issuable upon conversion of Series B Preferred Stock.
  • The company's reliance on related-party transactions, particularly with entities controlled by the CEO, could present conflicts of interest or governance risks.
  • The need for repeated stockholder meetings if the proposed share issuance is not approved, incurring additional costs and time.
  • The company's ability to raise capital may be impacted if the proposed share issuance is not approved, potentially hindering business plan implementation.

Future Outlook

The company is seeking stockholder approval for the issuance of shares to comply with Nasdaq rules and to facilitate the conversion of Series B Preferred Stock, which provided capital. The success of future business plans is dependent on maximizing capital raising opportunities.

Management Comments

  • Stockholders are urged to review the accompanying materials carefully and to vote as promptly as possible.
  • The Board believes that having the Chief Executive Officer also serving as the Chairman of the Board provides optimally effective leadership and is in the best interests of the company and its stockholders.
  • The Board recommends a vote FOR the election of director nominees, FOR the ratification of RBSM LLP, and FOR the approval of the Series B share issuance.

Industry Context

StockSavvy.ai notes that proxy statements are standard filings for public companies, particularly when seeking stockholder approval for significant share issuances or corporate actions. The focus on Nasdaq listing rules is typical for companies traded on that exchange. The extensive related-party transactions are a point of scrutiny in the current corporate governance landscape.

Comparison to Industry Standards

  • The election of directors and ratification of auditors are standard agenda items for annual meetings across all industries.
  • The requirement for stockholder approval for share issuances exceeding 20% of outstanding stock, as per Nasdaq Listing Rule 5635(d), is a common regulatory requirement for exchanges to prevent significant dilution without shareholder consent.
  • The structure of board committees (Audit, Compensation, Nominating/Governance, Sustainability) aligns with best practices for corporate governance in publicly traded companies.
  • The virtual meeting format is increasingly common, adopted by many companies to enhance accessibility and reduce costs, a trend accelerated by recent global events.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
Chief Financial OfficerIsaac DietrichChelsea Pullano2026-02-01Termination of Isaac Dietrich's employment in April 2025 and appointment of Chelsea Pullano in February 2026 in connection with a scope of work agreement with MACK Financial Solutions, LLC.
DirectorHenry Sicignano, III2025-02-14Resignation
DirectorJason Adelman2025-04-10Resignation
DirectorLisa Lucas-Burke2025-01-01Appointment

Related Party Transactions

  • Lease agreement for the Chesapeake location with an entity controlled by CEO Danny Meeks, with monthly rent of $9,000 increasing annually, extended for five years from January 1, 2025.
  • Issuance of 61 shares of Common Stock to CEO Danny Meeks in exchange for 250 shares of Series Z Preferred Stock on July 28, 2023.
  • Lease of 12 scrap yard facilities and equipment from an entity controlled by CEO Danny Meeks for $38,620 in 2025 and $1,502,830 in 2024.
  • Secured promissory note with an entity controlled by CEO Danny Meeks for $17,218,350 for equipment purchase, with a maturity date of July 31, 2043.
  • Exchange of 1,000 shares of Series D Preferred Stock for 12,121 shares of Common Stock with DWM Properties, LLC (controlled by CEO Danny Meeks) on May 10, 2024.
  • Purchase of vehicles from DWM (wholly owned by CEO Danny Meeks) for $3,582,181 on June 5, 2024.
  • Purchase of properties from DWM Properties LLC, KPAJ, LLC, and Oceana Salvage Properties, L.L.C. (affiliated with CEO Danny Meeks) for $15,000,000 on December 2, 2024, involving Series A-1 Preferred Stock and a DWM Note.
  • Exchange of a promissory note payable to DWM ($5,391,859) and other related party amounts ($2,608,141) for 2,152,853 shares of Common Stock with DWM Properties LLC on August 24, 2026.

Stakeholder Impact

  • Existing common stockholders face potential dilution from the proposed issuance of up to 3,571,429 shares.
  • Stockholders will have the opportunity to vote on director elections, auditor ratification, and the share issuance proposal.
  • Employees may be indirectly impacted by the company's financial health and strategic decisions influenced by the capital raise and governance matters.
  • Creditors may be impacted by the company's ability to raise capital and manage its financial obligations, particularly in light of deferred compensation and related-party debt.

Next Steps

  • Stockholders to vote on the proposed resolutions at the 2026 Annual Meeting of Stockholders.
  • If Proposal Three is not approved, the company may need to hold additional stockholder meetings semi-annually until approval is obtained.
  • The company will file a Form 8-K with preliminary voting results within four business days after the Annual Meeting.

Key Dates

DateDescription
2026-12-072026 Annual Meeting of Stockholders
2026-11-05Date of Proxy Statement mailing
2026-11-30Deadline for requesting additional information prior to the Annual Meeting
2026-12-03Deadline for beneficial owners to register for the virtual meeting
2026-10-23Record Date for determining stockholders entitled to vote
2027-07-08Deadline for submitting stockholder proposals for inclusion in 2027 proxy materials (Rule 14a-8)
2027-08-09Earliest date for stockholders to deliver notice for proposals for the 2027 annual meeting
2027-09-08Latest date for stockholders to deliver notice for proposals for the 2027 annual meeting

Recommendation

hold

The filing is procedural, outlining an annual meeting agenda. While the capital raise is positive, the significant potential dilution from the Series B Preferred Stock conversion and the extensive related-party transactions warrant caution. The company's financial stability is not detailed here, but past performance suggests ongoing challenges. Therefore, a 'hold' recommendation is appropriate pending further financial disclosures and clarity on the impact of these transactions.

Keywords

Annual Meeting, Proxy Statement, Stockholder Vote, Director Election, Auditor Ratification, Share Issuance, Preferred Stock Conversion, Nasdaq Listing Rule

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.